Detection equipment and detection method for rapidly and quantitatively detecting content of myocardial enzyme in blood

Through the binding of aptamer to myocardial enzymes and differential pulse voltammetry technology, combined with the high-affinity aptamer screened by the SELEX system, the existing myocardial enzyme detection methods are solved, and the problem of low aging and difficult quantitative detection is achieved, achieving rapid and accurate Multiple indicators have improved the reliability and efficiency of myocardial enzyme detection.

CN118937444APending Publication Date: 2024-11-12GUANGDONG MEDICAL UNIV
View PDF 0 Cites 2 Cited by

Patent Information

Application Number
CN202410840957.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-06-27
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

The existing myocardial enzyme detection methods are low in time, high in cost, and cannot achieve quantitative detection, which cannot meet the needs of early screening for myocardial infarction and heart failure.

Method used

The aptamer is bound to myocardial enzymes, and electrochemical detection is performed based on differential pulse voltammetry. Combined with the high-affinity aptamer screened by the SELEX system and nano-gold indium trioxide composite crystals, the precise quantitative detection of myocardial enzymes is achieved. And integrated into small devices.

Benefits of technology

It realizes fast and accurate quantitative detection, reduces misdiagnosis and missed diagnosis, has the characteristics of fast response speed, and can detect multiple specific indicators at the same time, improving the reliability and efficiency of the detection.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118937444A_ABST
    Figure CN118937444A_ABST
Patent Text Reader

Abstract

The invention discloses detection equipment and a detection method for rapidly and quantitatively detecting the content of myocardial enzyme in blood, and relates to the technical field of medical equipment.The equipment comprises a shell and an electrical interface, the shell is made of a firm material with excellent insulation performance, and the electrical interface is conveniently connected with external equipment to achieve data transmission and power supply; according to the invention, the aptamer is combined with myocardial enzyme, based on the characteristics of high specificity and strong stability of the aptamer, accurate and quantitative detection of target protein is realized, five specific indexes are detected at the same time, and myocardial infarction is early warned by troponin, myoglobin and creatine kinase isoenzyme; the natriuretic peptide and the C-reactive protein serve as auxiliary indexes for early warning of heart failure, the possibility of misdiagnosis and missed diagnosis can be reduced to the maximum extent, differential pulse voltammetry in the electrochemical method is adopted for detection in sequence, compared with other detection methods, the electrochemical method has the advantage of being high in response speed, and the rapid quantitative detection effect can be achieved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of medical equipment, in particular to a detection device and a detection method for rapid quantitative detection of the content of myocardial enzymes in blood. Background Art

[0003] At present, myocardial infarction and heart failure can only be discovered through clinical means. Commonly used clinical diagnostic methods include electrocardiogram, cardiac ultrasound and coronary angiography, but due to low timeliness and high cost, they cannot meet the needs of most patients. Some related products currently on the market have problems such as single detection indicators and inability to quantitatively detect, and the reliability of the test results is not high. Therefore, developing new accurate, economical and rapid means to screen in the early stages of heart failure is conducive to improving the cure rate, improving the quality of life of patients, and creating social and economic benefits. Therefore, it is necessary to propose a rapid quantitative detection device and method for the detection of myocardial enzyme content in blood to solve the problems in the existing technology. Summary of the invention

[0004] The purpose of the present invention is to make up for the shortcomings of the prior art and to provide a detection device and method for rapid quantitative detection of the content of myocardial enzymes in blood. It can use aptamers instead of antibodies to bind to myocardial enzymes. Based on the high specificity and strong stability of aptamers, accurate quantitative detection of target proteins can be achieved. Differential pulse voltammetry in the electrochemical method is used for detection in sequence. Compared with other detection methods, it has the characteristic of fast response speed.

[0005] In order to solve the above technical problems, the present invention provides the following technical solutions: a rapid quantitative detection device for the content of myocardial enzymes in blood, the device comprising:

[0006] The shell and electrical interface are made of strong materials with excellent insulation performance, and the electrical interface is easy to connect with external devices to achieve data transmission and power supply;

[0007] Test strip socket: There is an electrode port on the top of the device for inserting a special myocardial enzyme test strip;

[0008] Display screen, equipped with a high-resolution display screen, can clearly display the content value of myocardial enzymes, graphical trends and other relevant information during the test process;

[0009] Control button: The device is equipped with a power button / function button, through which users can easily start detection and select parameter operations;

[0010] The test paper has an aptamer layer disposed thereon, and the aptamer layer is immersed in a ferrocyanide compound liquid environment to improve the detection sensitivity, and a five-channel blood sampling threshold is provided inside the test paper to control the blood sampling volume;

[0011] Aptamer specific binding to myocardial protein technology. Aptamer is used to specifically bind to myocardial enzyme protein. Aptamer has high affinity, and the KD value reaches nm level or even pm level, ensuring high accuracy.

[0012] Differential pulse voltammetry technology, after the test paper is inserted into the electrode port, the difference between the current generated by the conversion of ferrocyanide compounds and the applied constant pulse current is generated, thereby accurately detecting the content of myocardial enzymes;

[0013] The current measuring device is used to measure the current peak change generated by differential pulse voltammetry, and reduce noise through the filter circuit, and the ADC converts it into a digital signal;

[0014] A digital circuit processing unit is used to process digital signals and derive a value of myocardial enzyme protein content after algorithm conversion;

[0015] The early warning circuit is used to set a threshold value for the myocardial enzyme content. When the myocardial enzyme content exceeds the threshold, the early warning circuit is triggered and three levels of alarm are issued according to the degree of excess of the myocardial enzyme content, so that users can judge their own probability of illness according to the alarm level and seek medical treatment in time.

[0016] Furthermore, the aptamer is constructed by a coupling pathway of hydrothermal and calcination to construct nano-gold indium trioxide composite crystals, and then the DNA is loaded on the crystals using the base grafting self-assembly technology. The aptamer set on the test paper is screened by the SELEX system and has the characteristics of high affinity for the myocardial enzyme protein to be detected.

[0017] Furthermore, the five-channel blood sampling threshold inside the test strip can simultaneously detect five specific indicators, including three indicators for warning of myocardial infarction (troponin, myoglobin, and creatine kinase isoenzymes) and two auxiliary indicators for warning of heart failure (natriuretic peptide and C-reactive protein).

[0018] Furthermore, the current measuring device is used to measure the current peak change generated by differential pulse voltammetry, and the specific execution steps of the ADC converting the digital signal into a digital signal are as follows:

[0019] Signal capture: When the differential pulse voltammetry detection device starts working, the current measuring device starts to capture the current signals transmitted by the detection electrode. These signals are the direct manifestation of the electrochemical reaction generated after the aptamer specifically binds to the myocardial enzyme;

[0020] Signal amplification: The captured current signal is often weak and needs to be amplified by an operational amplifier for subsequent processing and analysis. The basic amplification formula of the operational amplifier can be expressed as: V out =A v ×(V + -V - );

[0021] Filtering and noise reduction: Since there may be various interference signals in the environment, such as electromagnetic interference and temperature fluctuations, it is necessary to use a filtering circuit to reduce the noise of the signal to ensure the accuracy and reliability of the signal. In the filtering and noise reduction process, a low-pass filter is used with a cutoff frequency f c The relationship with the transfer function H(jω) can be expressed by the following formula, Where ω is the angular frequency, R is the resistance value, and C is the capacitance value;

[0022] Analog-to-digital conversion: The analog signal after filtering and noise reduction needs to be converted into a digital signal so that it can be processed by the digital circuit processing unit. This is achieved through the ADC converter, which converts the analog signal into a digital signal.

[0023] Furthermore, the analog-to-digital conversion process using an ADC converter mainly includes the following steps:

[0024] Sampling: Obtaining discrete samples of an analog signal within a certain time interval. This process discretizes the analog signal in time, that is, converting the continuous analog signal into a series of discrete sample points. The sampling frequency determines the number of samples sampled per second, usually in Hertz (Hz). The sampling frequency f s The bandwidth of the analog signal f b The relationship between is given by the sampling theorem, that is, f s >2f b ;

[0025] Quantization: Convert the continuous amplitude value of analog signal into discrete digital value. By mapping the amplitude value of analog signal to discrete levels, the discrete representation of analog signal is realized. Some errors may be introduced in the quantization process because the amplitude value of analog signal is continuous, while the amplitude value of digital signal can only take discrete values. Assuming that the amplitude range of analog signal is [V min ,V max ], the number of bits of ADC is n, then the quantization step length Δ can be given by the following formula:

[0026] Coding: Representing the quantized sample values ​​as binary data so that they can be stored or transmitted. Commonly used coding methods include binary coding and compression coding. The encoded digital signal can be processed and analyzed by the digital circuit processing unit.

[0027] Furthermore, the specific processing steps of the digital circuit processing unit are:

[0028] Signal reception: The digital circuit processing unit receives the digital signal from the current measuring device;

[0029] Data processing: The received digital signal first passes through a smoothing filter algorithm to eliminate noise and interference, using a moving average filter, the formula is: Where x[n] is the input signal, y[n] is the output signal, and N is the filter window size;

[0030] Data conversion: The data processed by the algorithm needs to be further converted to obtain the specific content value of myocardial enzyme protein. This conversion process is usually based on a calibration curve or mathematical model. It is assumed that there is a linear relationship model to describe the relationship between myocardial enzyme content (C) and measurement signal (S). The model can be expressed as: C = m·S + b, where m is the slope and b is the intercept;

[0031] Result output: The digital circuit processing unit will use the above linear relationship model to convert the measurement signal into a value of the myocardial enzyme protein content and display it to the user through the display screen.

[0032] Furthermore, the specific execution steps of the early warning circuit are:

[0033] Threshold setting: The warning circuit first sets the threshold of myocardial enzyme content based on medical research and clinical experience; these thresholds usually include normal range, first-level warning, second-level warning, and third-level warning.

[0034] Real-time monitoring: The early warning circuit monitors the myocardial enzyme protein content value output by the digital circuit processing unit in real time, and uses the resistance of the induction current change as the threshold setting point of each channel;

[0035] Judgment and warning: When the myocardial enzyme content is lower than the preset threshold, the warning circuit will trigger the corresponding alarm according to the degree of excess. If the current of any channel is lower than the threshold, it will be displayed as a first-level warning; if the current of any two or three channels is lower than the threshold, it will be displayed as a second-level warning; if the current of any four or five channels is lower than the threshold, it will be displayed as a third-level warning.

[0036] Furthermore, the execution steps of the aptamer specific binding myocardial protein technology are as follows:

[0037] Preparing aptamers: According to the desired detection target (i.e., myocardial protein), prepare corresponding aptamers, which are screened by, for example, the SELEX system, have high affinity and can specifically bind to specific myocardial proteins;

[0038] Sample processing: The subject uses a blood collection needle to collect blood from the finger, and the blood flows into the test paper through the capillary action of the test paper. The test paper is designed with five channels to ensure that the blood volume in the five channels meets the detection requirements;

[0039] Aptamers bind to myocardial proteins: When blood flows to the aptamer layer, the aptamers will specifically bind to myocardial proteins in the blood. This binding is based on the complementary structures and chemical properties between the aptamers and myocardial proteins, which enable them to bind tightly together.

[0040] Reaction waiting: To ensure that the aptamer is fully bound to the myocardial protein, you need to wait for ten minutes.

[0041] Furthermore, the differential pulse voltammetry technique is performed in the following steps:

[0042] Device preparation: While the aptamer is binding to the myocardial protein, the differential pulse voltammetry detection device and the current measuring device are also in a preparation state. A constant pulse current is passed through the device, and a test paper is inserted in the initial state to complete the connection of the detection electrodes;

[0043] Current detection: When the aptamer specifically binds to myocardial protein, a current change will occur inside the electrochemical reaction device. The detection electrode will detect this change, and the detection circuit will further detect the change in the current peak value;

[0044] Signal processing: The detected current signal is first processed by the filter circuit for noise reduction, and then converted into a digital signal by the ADC (analog-to-digital converter). The digital circuit will process these digital signals and derive the value of the myocardial enzyme protein content after algorithm conversion;

[0045] Early warning circuit: The early warning circuit will make judgments based on the value of the myocardial enzyme content.

[0046] A method for rapidly and quantitatively detecting the content of myocardial enzymes in blood, characterized in that the method comprises:

[0047] Insert the test strip into the electrode port of the device and start the device through the user interface;

[0048] The subject uses a blood collection needle to collect blood from the finger, and the blood enters the test strip through the capillary of the test strip until the thresholds of all five channels are met;

[0049] Open the valve in the test strip to allow blood to flow to the aptamer layer for specific binding reaction;

[0050] After waiting for ten minutes, the myocardial enzyme content was measured by differential pulse voltammetry technique and measuring current device;

[0051] The digital circuit processing unit processes the measured digital signal and derives the value of the myocardial enzyme protein content after conversion through an algorithm;

[0052] Issue early warning based on the comparison of myocardial enzyme levels with preset thresholds;

[0053] The test results are displayed and provided to the user for further analysis and processing.

[0054] Compared with the prior art, the rapid quantitative detection device and method for detecting the content of myocardial enzymes in blood have the following beneficial effects:

[0055] 1. The present invention combines aptamers with myocardial enzymes. Based on the high specificity and strong stability of aptamers, accurate quantitative detection of target proteins is achieved. Five specific indicators are detected at the same time. Troponin, myoglobin, and creatine kinase isoenzymes are used to warn of myocardial infarction. Natriuretic peptides and C-reactive protein are used as auxiliary indicators to warn of heart failure, which can greatly reduce the possibility of misdiagnosis and missed diagnosis. Differential pulse voltammetry in the electrochemical method is used for detection in sequence. The equilibrium dissociation constants KD values ​​of the five aptamers corresponding to the detection indicators of cardiac troponin, creatine kinase isoenzymes, myoglobin, natriuretic peptides, and C-reactive protein are all at the nanometer level, which is much smaller than similar antibodies. Compared with other detection methods, it has the characteristic of fast response speed, so that the present invention can achieve the effect of rapid quantitative detection.

[0056] 2. Compared with traditional detection equipment, the present invention integrates the detection function into a compact device. In terms of appearance, the instrument is of moderate size and easy to hold and operate. In addition, the surface of the device is treated with waterproof and anti-slip treatment, which improves the comfort and safety during use.

[0057] Other advantages, objectives and features of the present invention will be set forth in part in the following description and, in part, will be apparent to those skilled in the art based on an examination of the following or may be taught from the practice of the present invention. BRIEF DESCRIPTION OF THE DRAWINGS

[0058] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the prior art descriptions are briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention, and for ordinary technicians in this field, other drawings can be obtained based on these drawings without creative work.

[0059] Figure 1 It is a detection flow chart of a device for rapid quantitative detection of myocardial enzyme content in blood;

[0060] Figure 2 It is a flow chart of a detection method of a detection device for rapid quantitative detection of myocardial enzyme content in blood;

[0061] Figure 3 The schematic diagram is a structural diagram of a device for rapid quantitative detection of myocardial enzyme content in blood. DETAILED DESCRIPTION

[0062] The technical solutions in the embodiments of the present invention are described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0063] Embodiment 1

[0064] A device for rapidly and quantitatively detecting the content of myocardial enzymes in blood, the device comprising:

[0065] The outer shell and electrical interface are made of sturdy materials with excellent insulation performance to ensure that the equipment can operate stably in complex environments. The internally designed electrical interface and multi-functional chip have passed strict electromagnetic compatibility tests to ensure the stability and safety of the circuit. The electrical interface is easy to connect with external devices to achieve data transmission and power supply;

[0066] The shell is made of high-strength engineering plastic material with excellent insulation performance. The surface is specially treated, which is not only wear-resistant and corrosion-resistant, but also effectively resists electromagnetic interference, ensuring that the equipment can operate stably in complex environments. The surface of the shell is waterproof and anti-slip, which improves the comfort and safety during use.

[0067] Test strip socket: There is an electrode port on the top of the device for inserting a special myocardial enzyme test strip;

[0068] There is a dedicated test paper socket on the top of the device. The test paper socket adopts a precise electrode port design and is connected to the internal electrode circuit through high-precision welding technology to ensure that the current can be accurately transmitted to the test paper. The test paper adopts advanced biosensor technology and can quickly react specifically with myocardial enzymes in the blood, thereby accurately detecting the content of myocardial enzymes.

[0069] The display screen is equipped with a high-resolution display screen, which can clearly display the content value of myocardial enzymes, graphical trends and other relevant information during the test process. The display screen is intuitively designed and adopts a humanized interface design, which is convenient for users to quickly read and understand the test results. In addition, the display screen also has an automatic backlight adjustment function to adapt to the use needs in different light environments;

[0070] Control button: The device is equipped with a power button / function button. Users can easily start detection and select parameter operations through the button. The button design conforms to ergonomic principles, feels comfortable and is easy to operate.

[0071] The test paper is provided with an aptamer layer, which is immersed in a ferrocyanide compound liquid environment to improve the detection sensitivity. The test paper is provided with a five-channel blood sampling threshold inside to control the blood sampling volume, ensure that the blood sampling volume is appropriate, and avoid waste and pollution.

[0072] The five-channel blood sampling threshold inside the test strip can simultaneously detect five specific indicators, including three indicators for early warning of myocardial infarction (troponin, myoglobin, and creatine kinase isoenzymes) and two auxiliary indicators for early warning of heart failure (natriuretic peptide and C-reactive protein).

[0073] The aptamer is constructed by a coupling pathway of hydrothermal and calcination to construct a nano-gold indium trioxide composite crystal, and then the base grafting self-assembly technology is used to load DNA onto the crystal to complete the construction. Taking troponin as an example, the aptamer is placed in a potassium ferrocyanide environment. When blood flows to the aptamer through the capillary, the specific region of troponin will interact and bind with the aptamer through a non-covalent bond. The negative charge carried by the aptamer can disrupt the conversion between potassium ferrocyanide and potassium ferrocyanide in the natural state, causing the voltage peak to change. The accurate content of troponin can then be detected through the voltage peak difference.

[0074] The aptamer set on the test paper is screened by the SELEX system and has the characteristics of high affinity to the myocardial enzyme protein to be detected. The process of obtaining the aptamer through the SELEX system screening is a highly iterative and selective process. The following are the detailed implementation steps of the SELEX technology to screen the aptamer:

[0075] Library construction: First, a random oligonucleotide (such as DNA or RNA) library is constructed. This library contains a large number of oligonucleotides with different sequences, each of which represents a possible aptamer candidate. The size and complexity of the library depends on the specificity and affinity of the required aptamer.

[0076] Binding to the target molecule: Mix the oligonucleotides in the library with the target molecule (such as myocardial enzyme protein) and incubate them under specific conditions (such as temperature, pH value, ion concentration). During this process, some oligonucleotides will bind to the target molecule to form a stable complex;

[0077] Separation and elution: Use various physical or chemical methods (such as filtration, magnetic bead separation, chromatography) to separate oligonucleotides bound to the target molecule from unbound oligonucleotides. Through multiple washing steps, the purity of the bound oligonucleotides can be further improved.

[0078] Amplification: The separated binding oligonucleotides are subjected to PCR (polymerase chain reaction) or other appropriate amplification methods to increase their number. This step is one of the key steps of SELEX technology because it allows a large number of copies to be amplified from a small amount of binding oligonucleotides for the next round of screening.

[0079] Iterative screening: The amplified oligonucleotides are subjected to the next round of screening, and the above binding, separation, and amplification steps are repeated. In this process, oligonucleotides with stronger binding ability to the target molecule will be gradually enriched and selected. Usually, multiple rounds of iterative screening are required to obtain aptamers with high specificity and affinity;

[0080] Characterization and validation: The screened aptamers are subjected to sequence analysis, affinity determination, and specificity validation experiments to determine their performance and application potential. Various biophysical and biochemical methods (such as fluorescence resonance energy transfer and surface plasmon resonance) can be used to evaluate the performance of aptamers.

[0081] Through the above steps, SELEX technology can screen out aptamers with high specificity and affinity from a large random oligonucleotide library. These aptamers can be used in various biosensing, diagnosis, treatment and drug development fields. Aptamers are screened in this way and used to detect the content of myocardial enzymes in the blood.

[0082] Embodiment 2

[0083] Aptamer specific binding to myocardial protein technology. Aptamer is used to specifically bind to myocardial enzyme protein. Aptamer has high affinity, and the KD value reaches nm level or even pm level, ensuring high accuracy.

[0084] The execution steps of the aptamer specific binding to myocardial protein technology are as follows: according to the desired detection target (i.e., myocardial protein), prepare corresponding aptamers, which are screened by a system such as SELEX, have high affinity, and can specifically bind to specific myocardial proteins; the subject uses a blood collection needle to collect blood from the finger, and the blood flows into the inside of the test paper through the capillary action of the test paper. The inside of the test paper is designed with five channels to ensure that the blood volume in the five channels meets the detection requirements; when the blood flows to the aptamer layer, the aptamer will specifically bind to the myocardial protein in the blood. This binding is based on the complementary structure and chemical properties between the aptamer and the myocardial protein, which enables them to be tightly combined; in order to ensure that the aptamer is fully bound to the myocardial protein, it is necessary to wait for ten minutes.

[0085] Aptamers have the advantages of easy storage, high stability and low cost, and are widely used in detecting the content of various proteins. The present invention adopts aptamers screened by the SELEX system in the literature, which have high affinity for the myocardial enzyme protein to be detected, and its KD value reaches the nm level or even the pm level, ensuring the high accuracy of the present invention. At the same time, previous detections are mainly based on single myocardial enzyme detection, while the present invention integrates five myocardial enzyme detections to improve the versatility of the present invention. The aptamer specifically binds to the myocardial enzyme, affects the electrochemical reaction in the test paper, and is matched with a measuring current device to convert the numerical value, thereby realizing the measurement of myocardial enzyme content.

[0086] Differential pulse voltammetry technology, after the test paper is inserted into the electrode port, a difference is produced by applying a constant pulse current and the current generated by the conversion of ferrocyanide compounds, thereby accurately detecting the myocardial enzyme content. This technology has the advantages of fast detection speed and high sensitivity.

[0087] The execution steps of the differential pulse voltammetry technology are as follows: while the aptamer is binding to the myocardial protein, the differential pulse voltammetry detection device and the current measuring device are also in a ready state, a constant pulse current is passed through the device, and a test paper is inserted in the initial state to complete the connection of the detection electrode; when the aptamer is specifically bound to the myocardial protein, a current change will occur inside the electrochemical reaction device, and the detection electrode will detect this change, and the detection circuit will further detect the change in the current peak; the detected current signal is first subjected to noise reduction processing by a filter circuit, and then converted into a digital signal by an ADC (analog-to-digital converter), and the digital circuit will process these digital signals, and after algorithm conversion, the value of the myocardial enzyme protein content is derived; the early warning circuit will make a judgment based on the value of the myocardial enzyme content.

[0088] Differential pulse voltammetry has been widely used as an electrochemical method for the precise measurement of protein content. A constant pulse current is passed into the device, and a test strip is inserted in the initial state to complete the connection of the detection electrodes to form a complete differential pulse voltammetry detection device. After the aptamer specifically binds to the myocardial protein, the current changes inside the electrochemical reaction device. Through the detection electrode, the detection circuit detects the current peak change, and then the filter circuit reduces the noise. The ADC converts the digital signal, and the digital circuit processes the digital signal. After the algorithm is converted, the myocardial enzyme protein content value is derived, and the early warning circuit detects and sets a threshold. If the threshold is not exceeded, the circuit has no reaction. If the threshold is exceeded, the circuit is divided into three levels of early warning and lights up in turn to warn. The innovation of the present invention is that all five myocardial proteins are detected by differential pulse voltammetry. Previously, only one myocardial protein was detected by differential pulse voltammetry. All five myocardial proteins use differential pulse voltammetry, which can shorten the detection cycle to less than ten minutes, ensuring the efficiency of the invention.

[0089] Embodiment 3

[0090] The current measuring device is used to measure the current peak change generated by differential pulse voltammetry, and reduce noise through the filter circuit, and the ADC converts it into a digital signal;

[0091] The specific execution steps are as follows: when the differential pulse voltammetry detection device starts working, the current measuring device starts to capture the current signal transmitted by the detection electrode. These signals are the direct reflection of the electrochemical reaction generated after the aptamer specifically binds to the myocardial enzyme; the captured current signal is often weak and needs to be amplified by an operational amplifier for subsequent processing and analysis. The basic amplification formula of the operational amplifier can be expressed as: V out =A v ×(V + -V - ); Since there may be various interference signals in the environment, such as electromagnetic interference and temperature fluctuations, it is necessary to use a filtering circuit to reduce the noise of the signal to ensure the accuracy and reliability of the signal. In the filtering and noise reduction process, a low-pass filter is used with a cutoff frequency f c The relationship with the transfer function H(jω) can be expressed by the following formula, Among them, ω is the angular frequency, R is the resistance value, and C is the capacitance value; the analog signal after filtering and noise reduction needs to be converted into a digital signal so that it can be processed by the digital circuit processing unit, which is achieved through the ADC converter to convert the analog signal into a digital signal.

[0092] The process of analog-to-digital conversion using an ADC converter mainly includes the following steps: obtaining discrete samples of the analog signal at a certain time interval. This process discretizes the analog signal in time, that is, converts the continuous analog signal into a series of discrete sample points. The sampling frequency determines the number of samples sampled per second, usually in Hertz (Hz). The sampling frequency f s The bandwidth of the analog signal f b The relationship between is given by the sampling theorem, that is, f s >2f b ; Convert the continuous analog signal amplitude value into a discrete digital value. By mapping the analog signal amplitude value to discrete levels, the discrete representation of the analog signal is realized. Some errors may be introduced in the quantization process because the amplitude value of the analog signal is continuous, while the amplitude value of the digital signal can only take discrete values. Assume that the amplitude range of the analog signal is [V min ,V max ], the number of bits of ADC is n, then the quantization step length Δ can be given by the following formula: The quantized sample values ​​are represented as binary data so that they can be stored or transmitted. Common encoding methods include binary encoding and compression encoding. The encoded digital signals can be processed and analyzed by the digital circuit processing unit.

[0093] A digital circuit processing unit is used to process digital signals and derive a value of myocardial enzyme protein content after algorithm conversion;

[0094] The specific processing steps of the digital circuit processing unit are as follows: the digital circuit processing unit receives the digital signal from the current measuring device; the received digital signal first passes through a smoothing filter algorithm to eliminate noise and interference, using a moving average filter, the formula is: Where x[n] is the input signal, y[n] is the output signal, and N is the window size of the filter. Next, in order to extract key information related to the myocardial enzyme content, a peak detection algorithm can be used. The peak detection algorithm usually determines the position of the peak based on the derivative or difference of the signal. The specific formula of the peak detection algorithm depends on the specific implementation method; the data processed by the algorithm needs to be further converted to obtain the specific content value of the myocardial enzyme protein. This conversion process is usually based on a calibration curve or mathematical model. It is assumed that there is a linear relationship model to describe the relationship between the myocardial enzyme content (C) and the measurement signal (S). The model can be expressed as: C = m·S+b, where m is the slope and b is the intercept. These two parameters need to be determined through experiments or calibration processes; the digital circuit processing unit will use the above linear relationship model to convert the measurement signal into the content value of the myocardial enzyme protein and display it to the user through the display screen. .

[0095] The early warning circuit is used to set a threshold value for the myocardial enzyme content. When the myocardial enzyme content exceeds the threshold, the early warning circuit is triggered and three levels of alarm are issued according to the degree of excess of the myocardial enzyme content, so that users can judge their own probability of illness according to the alarm level and seek medical treatment in time.

[0096] The specific execution steps of the early warning circuit are: the early warning circuit first sets the threshold value of the myocardial enzyme content based on medical research and clinical experience; these thresholds usually include multiple levels of primary warning, secondary warning, and tertiary warning; the early warning circuit monitors the myocardial enzyme protein content value output by the digital circuit processing unit in real time, and uses the resistance of the induced current change as the threshold setting point for each channel; when the myocardial enzyme content is lower than the preset threshold, the early warning circuit will trigger a corresponding alarm according to the degree of excess, and if the current of any channel is lower than the threshold, it will be displayed as a primary warning; if the current of any two or three channels is lower than the threshold, it will be displayed as a secondary warning; if the current of any four or five channels is lower than the threshold, it will be displayed as a third-level warning.

[0097] Embodiment 4

[0098] A method for rapidly and quantitatively detecting the content of myocardial enzymes in blood, characterized in that the method comprises:

[0099] Insert the test strip into the electrode port of the device and start the device through the user interface;

[0100] The subject uses a blood collection needle to collect blood from the finger, and the blood enters the test strip through the capillary of the test strip until the thresholds of all five channels are met;

[0101] Open the valve in the test strip to allow blood to flow to the aptamer layer for specific binding reaction;

[0102] After waiting for ten minutes, the myocardial enzyme content was measured by differential pulse voltammetry technique and measuring current device;

[0103] The digital circuit processing unit processes the measured digital signal and derives the value of the myocardial enzyme protein content after conversion through an algorithm;

[0104] Issue early warning based on the comparison of myocardial enzyme levels with preset thresholds;

[0105] The test results are displayed and provided to the user for further analysis and processing.

[0106] Turn on the early warning instrument, insert the unused test paper into the electrode port, and assemble the complete detection device. The subject uses a blood collection needle to collect blood from his finger, and the blood enters the inside of the test paper through the capillary of the test paper. The test paper is set with blood collection thresholds for each channel, and blood collection reaches the thresholds of all five channels. Open the valve in the test paper, and the blood flows to the adapter layer for reaction. It is expected that after waiting for ten minutes, press the button to display the levels of five myocardial enzymes. The early warning system is in operation. If there is no myocardial enzyme content exceeding the standard, no light will be on. If there is a myocardial enzyme content exceeding the standard, it will be divided into three levels of alarms according to the number of types, and the probability of illness will be judged according to the alarm level, and go to the hospital for treatment in time.

[0107] The adapter layer of the test paper is immersed in the liquid environment of the ferrocyanide compound. After the test paper is inserted into the electrode port, a constant pulse is applied to the working electrode in the electrode port, which produces a difference with the current generated by the conversion of the ferrocyanide compound. The detection electrode detects the initial difference and performs intelligent zeroing through the instrument chip. When blood is collected, the test paper reserves a blood collection threshold for each channel. After blood is collected to the set threshold, the valve can be opened manually to react to avoid excessive blood collection. The myocardial enzyme in the blood combines with the adapter of each channel, interferes with the conversion reaction of the ferrocyanide compound, reduces the current generated by the reaction, and reduces the difference with the constant pulse current, and conducts current through the detection electrode; the amplifier circuit amplifies the current; the filter circuit reduces noise and reduces interference; the ADC performs digital signal conversion, and the data processing circuit performs algorithm conversion to display the value of the myocardial enzyme content in each channel. There is an early warning circuit in the instrument, which uses a resistor that senses current changes as the threshold setting for each channel. If the current in any channel is lower than the threshold, the first light switch can be closed and the first light can be turned on, which displays a first-level early warning; if the current in any two or three paths is lower than the threshold, the first and second light switches can be closed and the first and second lights can be turned on, which displays a second-level early warning; if the current in any four or five paths is lower than the threshold, the first, second, and third light switches can be closed and the first, second, and third lights can be turned on, which displays a third-level early warning.

[0108] It will be apparent to those skilled in the art that the invention is not limited to the details of the exemplary embodiments described above and that the invention can be implemented in other specific forms without departing from the spirit or essential features of the invention. Therefore, the embodiments should be considered in all respects as exemplary and non-limiting, and the scope of the invention is defined by the appended claims rather than the foregoing description, and it is intended that all variations falling within the meaning and scope of the same elements of the claims be included in the invention. Any reference numeral in a claim should not be considered as limiting the claim to which it relates.

Claims

1. A rapid quantitative detection device for myocardial enzyme content in blood, characterized in that: The device includes: The shell and electrical interface are made of sturdy materials with excellent insulation performance. The electrical interface is easy to connect with external devices to achieve data transmission and power supply; Test strip socket: There is an electrode port on the top of the device for inserting a dedicated myocardial enzyme test strip; Display screen, equipped with a high-resolution display screen, can clearly display the content value of myocardial enzymes, graphical trends and other relevant information during the test process; Control button: The device is equipped with a power button / function button, through which users can easily start detection and select parameter operations; The test paper is provided with an aptamer layer, which is immersed in a ferrocyanide liquid environment to improve detection sensitivity. The test paper is provided with a five-channel blood sampling threshold to control the blood sampling volume; Aptamer-specific binding to myocardial protein technology: Aptamers are used to specifically bind to myocardial enzyme proteins. Aptamers have high affinity, with KD values ​​reaching the nanometer or even pm level, ensuring high accuracy. Differential pulse voltammetry technology: after the test paper is inserted into the electrode port, the difference between the applied constant pulse current and the current generated by the conversion of ferrocyanide compounds is generated, thereby accurately detecting the content of myocardial enzymes; The current measuring device is used to measure the current peak change generated by differential pulse voltammetry, reduce noise through the filter circuit, and convert the ADC into a digital signal; A digital circuit processing unit is used to process digital signals and derive the value of myocardial enzyme protein content after algorithm conversion; The early warning circuit is used to set a threshold for myocardial enzyme content. When the myocardial enzyme content exceeds the threshold, the early warning circuit is triggered and three levels of alarm are set according to the degree of excess of the myocardial enzyme content. This allows users to judge their own probability of illness based on the alarm level and seek medical treatment in a timely manner.

2. A rapid quantitative detection device for myocardial enzyme content in blood according to claim 1, characterized in that: The aptamer is constructed by coupling hydrothermal and calcination to form nano-gold indium oxide composite crystals, and then the DNA is loaded onto the crystals using base grafting self-assembly technology. The aptamer set on the test paper is screened by the SELEX system and has the characteristics of high affinity for the myocardial enzyme protein to be detected.

3. The device for rapid quantitative detection of myocardial enzyme content in blood according to claim 1, characterized in that: The five-channel blood sampling threshold inside the test strip can simultaneously detect five specific indicators, including three indicators for warning of myocardial infarction (troponin, myoglobin, and creatine kinase isoenzyme) and two auxiliary indicators for warning of heart failure (natriuretic peptide and C-reactive protein).

4. The device for rapid quantitative detection of myocardial enzyme content in blood according to claim 1, characterized in that: The current measuring device is used to measure the current peak change generated by differential pulse voltammetry, and the specific execution steps of the ADC converting the digital signal into a digital signal through a filter circuit are as follows: Signal capture: When the differential pulse voltammetry detection device starts working, the current measuring device begins to capture the current signals transmitted by the detection electrodes. These signals are a direct reflection of the electrochemical reaction generated by the specific binding of the aptamer to the myocardial enzyme. Signal amplification: The captured current signal is often weak and needs to be amplified by an operational amplifier for subsequent processing and analysis. The basic amplification formula of the operational amplifier can be expressed as: V out =A v ×(V + -V - ); Filtering and noise reduction: Since there may be various interference signals in the environment, such as electromagnetic interference and temperature fluctuations, it is necessary to use a filtering circuit to reduce the noise of the signal to ensure the accuracy and reliability of the signal. In the filtering and noise reduction process, a low-pass filter is used with a cutoff frequency f c The relationship with the transfer function H(jω) can be expressed by the following formula, Where ω is the angular frequency, R is the resistance value, and C is the capacitance value; Analog-to-digital conversion: The analog signal after filtering and noise reduction needs to be converted into a digital signal so that it can be processed by the digital circuit processing unit. This is achieved through the ADC converter, which converts the analog signal into a digital signal.

5. The device for rapid quantitative detection of myocardial enzyme content in blood according to claim 4, characterized in that: The process of analog-to-digital conversion using an ADC converter mainly includes the following steps: Sampling: Obtaining discrete samples of an analog signal within a certain time interval. This process discretizes the analog signal in time, that is, converting the continuous analog signal into a series of discrete sample points. The sampling frequency determines the number of samples sampled per second, usually in Hertz (Hz). The sampling frequency f s The bandwidth of the analog signal f b The relationship between is given by the sampling theorem, that is, f s >2f b ; Quantization: Convert the continuous analog signal amplitude value into discrete digital value. By mapping the analog signal amplitude value to discrete levels, the discrete representation of the analog signal is realized. The quantization process may introduce some errors because the amplitude value of the analog signal is continuous, while the amplitude value of the digital signal can only take discrete values. Assume that the amplitude range of the analog signal is [V min ,V max ], the number of ADC bits is n, then the quantization step size Δ can be given by the following formula: Coding: Representing the quantized sample values ​​as binary data for storage or transmission. Common coding methods include binary coding and compression coding. The encoded digital signal can be processed and analyzed by the digital circuit processing unit.

6. The device for rapid quantitative detection of myocardial enzyme content in blood according to claim 1, characterized in that: The specific processing steps of the digital circuit processing unit are: Signal reception: The digital circuit processing unit receives the digital signal from the current measuring device; Data processing: The received digital signal first passes through a smoothing filter algorithm to eliminate noise and interference, using a moving average filter. The formula is: Where x[n] is the input signal, y[n] is the output signal, and N is the filter window size; Data conversion: The data processed by the algorithm needs to be further converted to obtain the specific content value of the myocardial enzyme protein. This conversion process is usually based on a calibration curve or mathematical model. It is assumed that there is a linear relationship model to describe the relationship between the myocardial enzyme content (C) and the measurement signal (S). This model can be expressed as: C = m·S + b, where m is the slope and b is the intercept; Result output: The digital circuit processing unit will use the above linear relationship model to convert the measurement signal into a numerical value of the myocardial enzyme protein content and display it to the user through the display screen.

7. The device for rapid quantitative detection of myocardial enzyme content in blood according to claim 1, characterized in that: The specific execution steps of the early warning circuit are: Threshold setting: The warning circuit first sets the threshold of myocardial enzyme content based on medical research and clinical experience; these thresholds usually include normal range, first-level warning, second-level warning, and third-level warning levels; Real-time monitoring: The early warning circuit monitors the myocardial enzyme protein content value output by the digital circuit processing unit in real time, and uses the resistance of the inductive current change as the threshold setting point of each channel; Judgment and warning: When the myocardial enzyme content is lower than the preset threshold, the warning circuit will trigger the corresponding alarm according to the degree of excess. If the current of any channel is lower than the threshold, it will be displayed as a level one warning; if the current of any two or three pathways is lower than the threshold, it will be displayed as a level two warning; if the current of any four or five pathways is lower than the threshold, it will be displayed as a level three warning.

8. The device for rapid quantitative detection of myocardial enzyme content in blood according to claim 1, characterized in that: The steps of the aptamer-specific myocardial protein binding technology are as follows: Preparation of aptamers: Based on the desired detection target (i.e., myocardial protein), corresponding aptamers are prepared. These aptamers are screened by, for example, the SELEX system and have high affinity and can specifically bind to specific myocardial proteins. Sample processing: The subject uses a lancet to collect blood from their finger. The capillary action of the test strip allows the blood to flow into the test strip. The test strip is designed with five channels to ensure that the blood volume in all five channels meets the test requirements. Aptamers bind to myocardial proteins: When blood flows to the aptamer layer, the aptamers specifically bind to myocardial proteins in the blood. This binding is based on the complementary structures and chemical properties between the aptamers and myocardial proteins, which enable them to bind tightly together. Reaction waiting time: To ensure that the aptamer is fully bound to the myocardial protein, you need to wait for ten minutes.

9. The device for rapid quantitative detection of myocardial enzyme content in blood according to claim 1, characterized in that: The steps for performing the differential pulse voltammetry technique are as follows: Device preparation: While the aptamer binds to the myocardial protein, the differential pulse voltammetry detection device and the current measurement device are also in the preparation state. A constant pulse current is passed through the device. In the initial state, the test paper is inserted to complete the connection of the detection electrodes. Current detection: When the aptamer specifically binds to myocardial protein, a current change occurs within the electrochemical reaction device. The detection electrode detects this change, and the detection circuit further detects the change in the current peak. Signal processing: The detected current signal is first processed by a filter circuit for noise reduction, and then converted into a digital signal by an ADC (analog-to-digital converter). The digital circuit processes these digital signals and, after algorithm conversion, derives the value of the myocardial enzyme protein content; Early warning circuit: The early warning circuit will make judgments based on the value of the myocardial enzyme content.

10. A method for rapid quantitative detection of myocardial enzyme content in blood, characterized in that: The method includes: Insert the test strip into the electrode port of the device and start the device through the user interface; The subject uses a lancet to collect blood from their finger, and the blood enters the test strip through the capillaries until all five channel thresholds are met; Open the valve inside the test strip to allow blood to flow to the aptamer layer for specific binding reaction; After waiting for ten minutes, the myocardial enzyme content was measured by differential pulse voltammetry technique and current measuring device; The digital circuit processing unit processes the measured digital signal and derives the value of the myocardial enzyme protein content after conversion through an algorithm; Issue early warning based on the comparison of myocardial enzyme levels with preset thresholds; The test results are displayed and provided to the user for further analysis and processing.

Citation Information

Cited By

  • Drug trace component high-throughput detection method based on enzyme specific reaction

    CN122337383A

  • High-throughput method for detecting trace components of pharmaceuticals based on enzyme-specific reactions

    CN122337383B